Baize Medical has submitted its IPO prospectus and plans to be listed in Hong Kong, with CMB International as the exclusive sponsor.

On December 13, 2024, Bayzed Health Group Inc (hereinafter referred to as "Bayzed Health Group"), from the Fengtai District of Peking, submitted a prospectus to the Hong Kong Stock Exchange, intending to be listed on the Main Board. This is a reapplication following the invalidation of its previous submission on April 26, 2024.

Ryanben CapitalDec 14 13:16

Baize Healthcare earns 350 million yuan a year but is not yet profitable. It says it is supported by Beijing Medicine and Beijing Oncology experts

On April 26, Baize Healthcare Group (hereinafter referred to as “Baize Healthcare”) submitted a prospectus on the Hong Kong Stock Exchange, with CMB International as the sole sponsor. According to Ruizai Financial Research, Baize Medical is an oncology medical group that invests in and provides medical-related services. As of the last practical date, Baize Medical has operated and managed eight hospitals in Beijing, Tianjin, Shanxi, Anhui and Henan provinces through direct equity ownership in six private for-profit hospitals and management rights for two private non-profit hospitals, focusing on providing full-cycle oncology medical services. In terms of performance, from 2021 to 2023, Baize Healthcare's revenue score

Le JuApr 29 10:45

Baize Medical, a private cancer hospital, went public in Hong Kong, and CMB International was the sole sponsor

① Baize Medical submitted an IPO application for Hong Kong stocks. What are the highlights of the company's business? ② The private oncology industry is growing rapidly. What is the room for future growth?

cls.cnApr 28 20:08